![Frédéric Fasano](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Frédéric Fasano
Direttore/Membro del Consiglio presso
Acesis Holdings Corp.
Profilo
Frédéric Fasano is currently a Director at the Institute of Corporate Directors, National Pharmaceutical Association, and Acesis Holdings Corp.
He was previously the President & Chief Executive Officer at Servier Canada, Inc. from 2006 to 2020.
He also served as the Chairman at Innovative Medicines Canada from 2017 to 2020 and as a Director at ILKOS THERAPEUTICS, Inc. from 2016 to 2020.
Mr. Fasano holds an MBA from ESSEC Business School and a doctorate from Université Paris-Saclay.
Posizioni attive di Frédéric Fasano
| Società | Posizione | Inizio |
|---|---|---|
Acesis Holdings Corp.
 Acesis Holdings Corp. BiotechnologyHealth Technology Functions as an investment holding company whose subsidiaries developing platform of oral drug candidates for metabolic and endocrine disorders | Direttore/Membro del Consiglio | - |
National Pharmaceutical Association
 National Pharmaceutical Association Miscellaneous Commercial ServicesCommercial Services The National Pharmaceutical Association is a company based in Phoenix. | Direttore/Membro del Consiglio | - |
Institute of Corporate Directors
 Institute of Corporate Directors Miscellaneous Commercial ServicesCommercial Services Promotes governance and develops leadership skills | Direttore/Membro del Consiglio | - |
Precedenti posizioni note di Frédéric Fasano
| Società | Posizione | Fine |
|---|---|---|
| VALEO PHARMA INC. | Presidente | 21/11/2022 |
ILKOS THERAPEUTICS, Inc.
 ILKOS THERAPEUTICS, Inc. BiotechnologyHealth Technology Operates biotechnology company | Direttore/Membro del Consiglio | 01/12/2020 |
Servier Canada, Inc.
 Servier Canada, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals for cardiology, diabetes, depression, venous disease and menopause | Amministratore Delegato | 01/11/2020 |
Innovative Medicines Canada
 Innovative Medicines Canada Miscellaneous Commercial ServicesCommercial Services Engages in research and development of medicines and vaccines | Presidente | 01/11/2020 |
Formazione di Frédéric Fasano
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
89
Relazioni di 1° grado
9
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 9 |
|---|---|
ESSEC Business School
 ESSEC Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Institute of Corporate Directors
Institute of Corporate Directors Miscellaneous Commercial ServicesCommercial Services Promotes governance and develops leadership skills | Commercial Services |
Servier Canada, Inc.
Servier Canada, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals for cardiology, diabetes, depression, venous disease and menopause | Health Technology |
Innovative Medicines Canada
Innovative Medicines Canada Miscellaneous Commercial ServicesCommercial Services Engages in research and development of medicines and vaccines | Commercial Services |
Valeo Pharma, Inc.
 Valeo Pharma, Inc. Medical DistributorsDistribution Services Wholesales and retails pharmaceuticals & hospital specialty products | Distribution Services |
ILKOS THERAPEUTICS, Inc.
ILKOS THERAPEUTICS, Inc. BiotechnologyHealth Technology Operates biotechnology company | Health Technology |
Université Paris-Saclay
 Université Paris-Saclay Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
National Pharmaceutical Association
National Pharmaceutical Association Miscellaneous Commercial ServicesCommercial Services The National Pharmaceutical Association is a company based in Phoenix. | Commercial Services |
Acesis Holdings Corp.
Acesis Holdings Corp. BiotechnologyHealth Technology Functions as an investment holding company whose subsidiaries developing platform of oral drug candidates for metabolic and endocrine disorders | Health Technology |
